期刊文献+

SPARC蛋白在乳腺癌组织中的表达及临床意义 被引量:7

Expression and Clinical Significance of SPARC Protein in Breast Cancer
下载PDF
导出
摘要 目的探讨富含半胱氨酸的分泌性酸性蛋白(SPARC)在乳腺癌组织的表达及其临床意义。方法收集1997年至2008年在我院行根治性手术的255例有完整随访资料的乳腺癌肿瘤组织石蜡标本,采用组织芯片制作和免疫组化方法检测SPARC蛋白在乳腺癌组织中的表达,分析其与临床病理因素及预后的关系。结果乳腺癌组织SPARC蛋白阳性表达率为76.1%,SPARC在乳腺癌组织中的表达与病理类型(P=0.007)及激素受体状态(P=0.034)相关。SPARC是否阳性表达对乳腺癌患者的无病生存时间(DFS)(P=0.451)、总生存时间(OS)(P=0.562)未显示出有统计学差别,亚组分析显示:绝经前SPARC阴性组患者的DFS优于SPARC阳性组患者的DFS,差别有统计学意义(P=0.013)。多因素Cox比例风险回归分析显示SPARC不是浸润性乳腺癌复发及死亡的独立预后因素。结论SPARC蛋白在乳腺癌的发生、发展中起一定作用,它与雌激素受体表达密切相关,可能是影响绝经前乳腺癌预后的重要指标。 Objective To study the expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer, and explore its clinical significance. Methods A total of 255 tumor specimens of radical operation for breast cancer were collected in the First Hospital of China Medical University from 1997 to 2008. The expression of SPARC protein in breast cancer tissues was detected by tissue chips and , and its relationship with clinicopathological factors was analyzed. Results The expression rate of SPARC was 76.1% in breast cancer tissues. The positive expression of SPARC protein was related to invasive ductal carcinoma ( P = 0.007 ), hormone receptor state (P = 0.034), and ER state (P = 0.040) . There was no significant difference of the disease-free survival (DFS) (P = 0.451 ) or overall survival (OS) (P = 0.562) between breast cancer patients with/without SPARC expression. Subgroup analysis showed that premenopansal DFS is significantly better than that of SPARC positive patients with SPARC negative group DFS (P = 0.013 ). Multivariate Cox proportional hazard regression analysis showed that SPARC is not recurrence and mortality of independent prognostic factors invasive breast cancer. Conclusion SPARC protein played an important role in the genesis and development of breast cancer, and was closely related with the expression of estrogen receptor, which could be an important index in premeno- pausal breast cancer prognosis.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2014年第6期493-498,共6页 Journal of China Medical University
基金 国家自然科学基金(81172535) 辽宁省科学技术计划(2010225032) 辽宁省教育厅高校科研计划(L2010698)
关键词 乳腺癌 富含半胱氨酸的分泌性酸性蛋白 免疫组化 预后 breast cancer secreted protein acidic and rich in cysteine protein immunohistochemistry prognosis
  • 相关文献

参考文献18

  • 1Siegel R, Naishadham D, Jemal A.Cancer statistics, 2013[J].CA Cancer J Clin,2013,63(1): 11-30. 被引量:1
  • 2冯丹,蔡建,张颖一,卫子然,王雅杰.SPARC在恶性肿瘤中的研究进展[J].医学研究杂志,2011,40(10):13-16. 被引量:5
  • 3朱璐(综述),金平(审校).富含半胱氨酸的酸性分泌蛋白与恶性肿瘤[J].国际肿瘤学杂志,2010,37(7):504-507. 被引量:4
  • 4Alexandre C, Susan L.Modulation of matrix remodeling by SPARC in neoplastic progression [J].Semin Cell Dev Biol, 2010, 21 (1) :55-65. 被引量:1
  • 5Nie J, Sage EH.SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling[J].J Biol Chem, 2009,284 (2) : 1279-1290. 被引量:1
  • 6刘晓梅,于国华,张居民,刘淑真,高艳芳,苏峥.乳腺癌组织SPARC和VEGF表达临床意义的探讨[J].中华肿瘤防治杂志,2012,19(14):1061-1065. 被引量:7
  • 7Schellings MV, Vanhoutte D, Swinnen M, et al.Absence of SPARC results in increased cardiac rupture and dysfuns- tion after acute myocardial infarction [J] .J Exp Med, 2009,206 (1): 113-123. 被引量:1
  • 8Barth PJ, Moll R, Ramaswamy A.Stromal remodeling and SPARC (secreted protein acid rich in cysteine)expression in invasive duc- tal carcinomas of the breast [J].Virchows Arch, 2005, 446 (5) : 532-536. 被引量:1
  • 9Hsiao YH, Lien HC, Hwa HL, et al. SPARC (Osteonectin) in breast tumors of different histologic types and its role in the outcomes of in- vasive duetal carcinoma [J]. Breast J, 2010,16 (3): 305-308. 被引量:1
  • 10Graham JD, Balleine RL, Milliken JS, et al. Expression of osteonec- tin mRNA in human breast tumours is inversely correlated with oestrogen receptor content [J]. Eur J Cancer, 1997, 33 (10) : 1654-1660. 被引量:1

二级参考文献58

  • 1Framson PE,Sage EH.SPARC and rumor growth:where the seed meets the soil? J Cell Biochem,2004,92(4):679-690. 被引量:1
  • 2Suzuki M,Hao C,Takahashi T,et al.Aberrant methylation of SPARC in human lung cancers.Br J Cancer,2005,92(5):942-948. 被引量:1
  • 3Dimartino JF,Lacayo NJ,Varadi M,et al.Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is associated with sensitivity to growth inhibition by exogenous SPARC protein.Leukemia,2006,20(3):426-432. 被引量:1
  • 4Heller G,Schmidt WM,Ziegler B,et al.Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells.Cancer Res,2008,68(1):44-54. 被引量:1
  • 5Kahn SL,Ronnett BM,Gravitt PE,et al.Quantitative methylationspecific PCR for the detection of aberrant DNA methylation in liquidbased Pap tests.Cancer,2008,114(1):57-64. 被引量:1
  • 6Yang E,Kang HJ,Koh KH,et al.Frequent inactivation of SPARC by promoter hypermethylation in colon cancers.Int J Cancer,2007,121 (3):567-575. 被引量:1
  • 7Sato N,Fukushima N,Matsubayashi H,et al.Aberrant methylation of Reprimo correlates with genetic instability and predicts poor prognosis in pancreatic ductal adenocarcinoma.Cancer,2006,107 (2):251-257. 被引量:1
  • 8Soeha MJ,Said N,Dai Y,et al.Aberrant promoter methylation of SPARC in ovarian cancer.Neoplasia,2009,11(2):126-135. 被引量:1
  • 9Rodriguez-Jimenez FJ,Caldes T,Iniesta P,et al.Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma.Oncol Rep,2007,17(6):1301-1307. 被引量:1
  • 10Yiu GK,Chan WY,Ng SW,et al.SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells.Am J Pathol,2001,159(2):609-622. 被引量:1

共引文献13

同被引文献59

  • 1乔爱君,左瑾,刘晓军,邵迪,朱鏐娈,崔安芳,孔星星,方福德,常永生.Sirt1基因的研究进展[J].中国医学科学院学报,2009,31(6):782-785. 被引量:5
  • 2郑英娟,汤建华,张志林,张志华,张秀珑,冯平.肺癌中SPARC和TGFβ1的表达及意义[J].肿瘤防治研究,2014,41(6):593-597. 被引量:5
  • 3傅少梅,殷初阳,宋晖.miR-340在三阴性乳腺癌的表达和意义[J].中国生化药物杂志,2014,34(1):72-73. 被引量:3
  • 4Brekken RA, Sage EH. SPARC, a matricellular pro-tein : at the crossroads of cell-matrix communica-tion [J]. Matrix Bi- ol, 2001,19(18) :816-827. 被引量:1
  • 5Mok SC, Chan WY, Wong KK, et al. SPARC, an extracel- lular matrix protein with tumor-suppressing activity in human ovarian epithelial cells [J]. Oncogene,2012,12 : 1895-1901. 被引量:1
  • 6Thomas R,True LD, Bassuk JA, et al. Different expression of osteonectin/SPARC during human prostate cancer pro- gression [J]. Clin Cancer Res, 2000,6 : 1140-1149. 被引量:1
  • 7Puolakkainen PA,Brekken RA,Muneer S,et al. Enhanecd growth of pancreatic tumors in SPARC-nullmice is associ- ated with decreased deposition of extracellul armatrix and reduced tumor cell apoptosis [J]. MolCancer Res,2004, 2(4) :215-224. 被引量:1
  • 8Rotllant J,Liu D,Yan YL, et al. Sparc (Osteonectin) func- tions in morphogenesis of the pharyngeal skeleton and inner ear [J]. Matrix Bio1,2008,27:561-572. 被引量:1
  • 9Marcia CH. Mamma lian sintuins emerging roles in physi- ology,aging and calorie restriction [J]. Gen Dev, 2008,20 (21) :2913-2921. 被引量:1
  • 10Wang H,Liu H,Chen K,et al. SIRT1 promotes tumori- genesis of hepatocellular carcinoma through PI3K/PTEN/ AKT signaling [J]. On-col Rep, 2012,28 : 311-318. 被引量:1

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部